Home LiteratureArticle Details
PMID: 9882352 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.

Journal of virology ·Vol. 73 ·No. 2 ·1999-02-00 ·Pages 1460-7

Dettenhofer M, Yu XF

Abstract

The vif gene of human immunodeficiency virus type 1 (HIV-1) is essential for the productive infection of primary blood-derived lymphocytes, macrophages, and certain human T-cell lines. It has been shown that Vif is associated with HIV-1 virions purified by sucrose density-equilibrium gradient analysis. However, the specificity of Vif incorporation into virions has not been determined. Moreover, recent studies have demonstrated that standard HIV-1 particle preparations created with sucrose density-equilibrium gradients are contaminated with cell-derived microvesicles. Here we demonstrate, as previously reported, that Vif cosediments with HIV-1 particles in sucrose density-equilibrium gradient analysis. However, we also found that, when Vif was expressed in the absence of all other HIV-1-encoded gene products and then isolated by sucrose density-equilibrium gradient centrifugation from extracellular supernatants, its sedimentation pattern was largely unaltered, suggesting that Vif can be secreted from cells. Using a newly developed OptiPrep velocity gradient method, we were able to physically separate most of the extracellular Vif from the HIV-1 virions without disrupting the infectivity of the virus. By titrating serial dilutions of purified Vif and Gag against the viral peak fraction in the OptiPrep gradient, we demonstrate that <1.0 Vif molecule per virion was present. This study shows that Vif is not significantly present in HIV-1 virions, a finding which is consistent with the idea that Vif functions predominantly in the virus-producing cells during virus assembly. The OptiPrep velocity gradient technique described here could be an easy and rapid way to purify HIV and other enveloped viruses from microvesicles and/or cell debris.

MeSH Terms
Animals COS Cells Centrifugation, Density Gradient Gene Products, vif/isolation & purification HIV-1 Humans Virion vif Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, vif vif Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dettenhofer M
Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205, USA.
Yu X F
References (63)
63 references, click to expand
  1. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    J Virol. 1995 Apr;69(4):2058-67 PMID: 7884851
  2. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    J Virol. 1992 Nov;66(11):6489-95 PMID: 1357189
  3. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    J Virol. 1995 May;69(5):2759-64 PMID: 7707498
  4. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
    J Virol. 1995 Jul;69(7):4582-6 PMID: 7769728
  5. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    J Virol. 1995 Nov;69(11):6873-9 PMID: 7474102
  6. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
    J Virol. 1995 Nov;69(11):7196-204 PMID: 7474141
  7. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    J Virol. 1995 Dec;69(12):7630-8 PMID: 7494271
  8. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain.
    AIDS Res Hum Retroviruses. 1995 Sep;11(9):1003-6 PMID: 8554896
  9. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    J Virol. 1996 Jan;70(1):341-51 PMID: 8523546
  10. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
    J Virol. 1996 Jan;70(1):494-507 PMID: 8523563
  11. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
    J Gen Virol. 1995 Dec;76 ( Pt 12):3171-9 PMID: 8847526
  12. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
    Virology. 1996 May 1;219(1):228-36 PMID: 8623533
  13. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
    J Virol. 1996 Jun;70(6):3551-60 PMID: 8648689
  14. HIV-1 Gag protein associates with F-actin present in microfilaments.
    Virology. 1996 Jun 15;220(2):530-4 PMID: 8661406
  15. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    J Virol. 1996 Jul;70(7):4283-90 PMID: 8676450
  16. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
    J Virol. 1996 Sep;70(9):6106-11 PMID: 8709234
  17. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.
    J Virol. 1996 Aug;70(8):5297-305 PMID: 8764040
  18. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.
    J Virol. 1996 Nov;70(11):7734-43 PMID: 8892894
  19. Direct interaction between the envelope and matrix proteins of HIV-1.
    EMBO J. 1996 Nov 1;15(21):5783-8 PMID: 8918455
  20. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
    J Virol. 1996 Dec;70(12):8263-9 PMID: 8970945
  21. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
    J Virol. 1996 Dec;70(12):8701-9 PMID: 8970997
  22. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.
    Cell. 1996 Dec 27;87(7):1285-94 PMID: 8980234
  23. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
    J Gen Virol. 1997 Mar;78 ( Pt 3):627-35 PMID: 9049414
  24. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.
    Virology. 1997 Mar 31;230(1):125-33 PMID: 9126268
  25. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.
    Virology. 1997 Mar 31;230(1):134-44 PMID: 9126269
  26. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.
    J Virol. 1997 Jul;71(7):5259-67 PMID: 9188594
  27. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
    J Virol. 1992 Nov;66(11):6616-25 PMID: 1357190
  28. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    J Virol. 1993 Jan;67(1):213-21 PMID: 8416370
  29. The sor gene of HIV-1 is required for efficient virus transmission in vitro.
    Science. 1987 Aug 21;237(4817):888-93 PMID: 3497453
  30. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  31. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.
    Science. 1992 Dec 18;258(5090):1935-8 PMID: 1470916
  32. Human immunodeficiency virus vpr product is a virion-associated regulatory protein.
    J Virol. 1990 Jun;64(6):3097-9 PMID: 2139896
  33. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein.
    J Virol. 1990 Nov;64(11):5688-93 PMID: 2145446
  34. Human immunodeficiency virus vpr gene encodes a virion-associated protein.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1265-71 PMID: 2150318
  35. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
    Nature. 1991 Apr 11;350(6318):508-11 PMID: 2014052
  36. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  37. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
    J Virol. 1992 Aug;66(8):4966-71 PMID: 1629961
  38. Cell-free transmission of Vif mutants of HIV-1.
    Virology. 1992 Sep;190(1):19-29 PMID: 1529528
  39. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.
    J Virol. 1993 Mar;67(3):1663-6 PMID: 8437236
  40. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
    Cell. 1993 Jun 18;73(6):1067-78 PMID: 8513493
  41. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  42. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    J Virol. 1993 Oct;67(10):6322-6 PMID: 8371360
  43. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.
    J Virol. 1993 Nov;67(11):6542-50 PMID: 8411357
  44. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    J Virol. 1993 Dec;67(12):7229-37 PMID: 8230445
  45. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1994 Mar;68(3):1689-96 PMID: 8107229
  46. Role of vif during packing of the core of HIV-1.
    Virology. 1994 Jun;201(2):349-55 PMID: 8184544
  47. Specific incorporation of cyclophilin A into HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):359-62 PMID: 7969494
  48. Functional association of cyclophilin A with HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):363-5 PMID: 7969495
  49. The preparation of subcellular organelles from mouse liver in self-generated gradients of iodixanol.
    Anal Biochem. 1994 Aug 1;220(2):367-73 PMID: 7978280
  50. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
    J Virol. 1997 Aug;71(8):5871-7 PMID: 9223476
  51. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    J Virol. 1997 Sep;71(9):6973-81 PMID: 9261426
  52. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
    J Virol. 1997 Dec;71(12):9358-65 PMID: 9371595
  53. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
    Nat Med. 1998 Jan;4(1):65-71 PMID: 9427608
  54. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.
    Genes Dev. 1998 Jan 15;12(2):175-85 PMID: 9436978
  55. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.
    EMBO J. 1998 Feb 16;17(4):909-17 PMID: 9463369
  56. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells.
    Virology. 1998 Mar 30;243(1):78-93 PMID: 9527917
  57. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.
    Vaccine. 1998 Jan-Feb;16(2-3):119-29 PMID: 9607019
  58. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    J Virol. 1997 Mar;71(3):2473-7 PMID: 9032385
  59. Complete nucleotide sequence of the AIDS virus, HTLV-III.
    Nature. 1985 Jan 24-30;313(6000):277-84 PMID: 2578615
  60. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.
    Science. 1986 Mar 28;231(4745):1546-9 PMID: 3006243
  61. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
    Science. 1986 Mar 28;231(4745):1549-53 PMID: 3006244
  62. Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.
    Science. 1986 Mar 28;231(4745):1553-5 PMID: 3006245
  63. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    J Virol. 1995 Apr;69(4):2068-74 PMID: 7884852
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-02-00
Pages
1460-7
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC103971
Subset
IM
Grants
NIEHS NIH HHS · T32 ES007141 · United States
NIEHS NIH HHS · ES07141 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]